Veno-venous extracorporeal membrane oxygenation for COVID-19-associated pediatric acute respiratory distress syndrome.
COVID-19
acute respiratory distress syndrome
extracorporeal membrane oxygenation
pediatric critical care
veno-venous extracorporeal membrane oxygenation
Journal
Perfusion
ISSN: 1477-111X
Titre abrégé: Perfusion
Pays: England
ID NLM: 8700166
Informations de publication
Date de publication:
09 2020
09 2020
Historique:
pubmed:
10
7
2020
medline:
28
8
2020
entrez:
10
7
2020
Statut:
ppublish
Résumé
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) coronavirus has emerged as a highly contagious respiratory pathogen causing severe acute lung injury. Extracorporeal membrane oxygenation is a standard tool for the management of life-threatening acute respiratory distress syndrome, but the use of this resource-intensive therapy has come into question due to strained medical systems and limited proven treatments for COVID-19. A 16-year-old female with obesity presented with fever, myalgias, cough, and tachypnea and was diagnosed with COVID-19. She progressed to severe pediatric acute respiratory distress syndrome requiring intubation on hospital day 4 and cannulation to veno-venous extracorporeal membrane oxygenation on hospital day 6. The patient received remdesivir, steroids, and anakinra. The patient was successfully decannulated on hospital day 12 and was discharged home on hospital day 21. We report the use of veno-venous extracorporeal membrane oxygenation as a bridge to lung recovery in a pediatric patient with severe pediatric acute respiratory distress syndrome due to COVID-19.
Sections du résumé
BACKGROUND
The SARS-CoV-2 (severe acute respiratory syndrome coronavirus 2) coronavirus has emerged as a highly contagious respiratory pathogen causing severe acute lung injury. Extracorporeal membrane oxygenation is a standard tool for the management of life-threatening acute respiratory distress syndrome, but the use of this resource-intensive therapy has come into question due to strained medical systems and limited proven treatments for COVID-19.
CASE SUMMARY
A 16-year-old female with obesity presented with fever, myalgias, cough, and tachypnea and was diagnosed with COVID-19. She progressed to severe pediatric acute respiratory distress syndrome requiring intubation on hospital day 4 and cannulation to veno-venous extracorporeal membrane oxygenation on hospital day 6. The patient received remdesivir, steroids, and anakinra. The patient was successfully decannulated on hospital day 12 and was discharged home on hospital day 21.
CONCLUSION
We report the use of veno-venous extracorporeal membrane oxygenation as a bridge to lung recovery in a pediatric patient with severe pediatric acute respiratory distress syndrome due to COVID-19.
Identifiants
pubmed: 32643551
doi: 10.1177/0267659120939757
pmc: PMC7988685
mid: NIHMS1682471
doi:
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
550-553Subventions
Organisme : NIGMS NIH HHS
ID : K08 GM132794
Pays : United States
Références
Heart Lung. 2020 Jul - Aug;49(4):348-349
pubmed: 32223988
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Lancet. 2020 May 16;395(10236):1569-1578
pubmed: 32423584
Pediatrics. 2020 Jun;145(6):
pubmed: 32179660
JAMA. 2020 Apr 7;323(13):1245-1246
pubmed: 32074258
ASAIO J. 2020 May;66(5):475-481
pubmed: 32243266
Obesity (Silver Spring). 2020 Jul;28(7):1195-1199
pubmed: 32271993
J Crit Care. 2020 Aug;58:27-28
pubmed: 32279018
Int J Infect Dis. 2020 May;94:78-80
pubmed: 32251794
Thromb Res. 2020 Jul;191:145-147
pubmed: 32291094